Concepedia

Wajd Alkabbani

WA

8

Publications

164

Citations

8

H-Index

2019

Active since

Affiliations

University of Waterloo(Current)

University of Toronto

University of Manitoba

Women's College Hospital

University of Alberta

Wajd Alkabbani is an author at University of Waterloo specializing in pharmacotherapy, medicine, and chronic kidney disease.

ORCID

Top concepts

Publications per year

2019–2024

8

Publications

8

Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study

Wajd Alkabbani, Karine Suissa, KRISTINE D. GU et al. · BMJ · 2024 · 43 citations · Full text

Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study

Wajd Alkabbani, Arsène Zongo, Jasjeet K. Minhas‐Sandhu et al. · Canadian Journal of Diabetes · 2021 · 30 citations

, , +10

Active‐comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors

Wajd Alkabbani, John‐Michael Gamble · British Journal of Clinical Pharmacology · 2021 · 26 citations · Full text

Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population‐based cohort study

Wajd Alkabbani, Ruth Ann Marrie, Shawn Bugden et al. · Addiction · 2019 · 17 citations

Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study

Wajd Alkabbani, Colleen J. Maxwell, Ruth Ann Marrie et al. · Diabetes Care · 2022 · 15 citations

Rows per page

1–5 of 8